Cannabis Stock News
Latest updates, earnings, and regulatory news for marijuana stocks
Cannabismarketcap aggregates cannabis news from over 20 leading industry sources including Marijuana Moment, MJBizDaily, New Cannabis Ventures, Benzinga Cannabis, and more. Every article is AI-rewritten into an original summary so you get the key facts without the clutter. The feed updates automatically every 30 minutes throughout the trading day, ensuring you never miss a market-moving headline.
Coverage spans earnings reports, regulatory developments, state-level legalization updates, M&A activity, analyst ratings, and executive leadership changes across the publicly traded cannabis sector. Articles are tagged with relevant stock tickers so you can quickly see which companies are in the news. For company-specific coverage, visit any stock page and navigate to its dedicated news tab.
Ohio Hemp Restrictions Advance as Opposition Campaign Falls Short
Failed ballot initiative clears path for Republican lawmakers to restrict intoxicating hemp products, threatening industry revenue streams and market access.
Record Cannabis Yields Achieved With Precision Stone-Wool Growing Systems
Commercial cannabis trials at a Montreal research facility produced average dry flower yields of 9.7 kg/m², with peak results exceeding 10 kg/m², using optimized stone-wool substrates and F1 hybrid autoflower genetics.
Biotech Rally Signals Growing Investor Appetite for Cannabis Therapeutics
Recent clinical trial successes in neurological treatments highlight the expanding pharmaceutical applications of cannabis-derived compounds as biotech valuations climb.
Cannabis Health Stocks Mirror Broader Healthcare Discount Trend
Healthcare sector valuations hit multi-year lows, creating opportunities in cannabis pharmaceutical plays as investors reassess risk premiums across medical markets.
Virginia Approves Cannabis Retail Sales Framework After 5-Year Gap
Virginia lawmakers pass legislation enabling legal cannabis sales by late 2024, ending five-year period where possession was legal but purchases weren't.
Institutional Cannabis Investors Shift Focus as Tech Exits Accelerate
Major fund liquidations in adjacent sectors signal broader capital reallocation trends affecting cannabis investment flows and market dynamics.
Cannabis Normalization Accelerates Through Celebrity Endorsements
High-profile athletes openly discussing cannabis use signals shifting cultural attitudes that could drive broader market acceptance and regulatory momentum.
Cannabis Tax Hikes Fail to Reduce Consumption, New Research Reveals
Scientific analysis challenges high-tax strategy, suggesting policy could push consumers toward illicit markets while undermining legal operators' revenue growth.
White House Drug Czar Sidelines Cannabis Reform for Fentanyl Focus
New drug czar Sara Carter prioritizes opioid crisis over marijuana policy, signaling federal cannabis reform takes backseat despite industry expectations.
Ohio Bans Intoxicating Hemp Sales, Caps Cannabis THC Levels
Ohio implements sweeping cannabis reforms this week, banning intoxicating hemp products while capping THC at 70% for concentrates and 35% for flower.
Massachusetts Deploys $29M Cannabis Equity Fund to Reshape Market Access
Bay State allocates record social equity funding as operators face capital constraints and market consolidation pressures.
Missouri Cannabis Market Emerges as Unexpected Revenue Leader
Show-Me State generates $1.2B+ in adult-use sales since 2023 launch, outpacing projections and attracting multi-state operator expansion plans.
Federal Cannabis Laws Create $50B Market Access Risk for Immigrants
Despite state legalization, federal prohibition puts non-citizens at deportation risk, limiting market expansion potential for cannabis operators nationwide.
Cannabis Industry Eyes Medicare Advantage Market Shift
Healthcare policy changes could reshape medical cannabis access for 26 million seniors, creating new market dynamics for operators targeting aging demographics.
Virginia Cannabis Bill Favors Incumbents Over New Market Entrants
Virginia's legalization framework creates competitive advantages for established operators, potentially limiting market access for new players in the emerging adult-use sector.
DEA Data Confirms Youth Cannabis Use Drops Despite State Legalization
Federal drug agency acknowledges declining youth marijuana consumption amid expanding legal markets, potentially strengthening case for further regulatory reform.
Congress Cannabis Rescheduling Report Sparks Market Volatility
New congressional analysis on federal cannabis rescheduling triggers investor uncertainty as multi-state operators reassess regulatory timelines and market positioning.
South Dakota Legalizes Synthetic Psilocybin for Mental Health Treatment
Republican Governor Larry Rhoden signs legislation authorizing synthetic psilocybin therapy, contingent on federal approval, expanding psychedelic medicine access.
Canada's Illicit Cannabis Crackdown Intensifies in Nova Scotia
RCMP enforcement actions against unlicensed dispensaries highlight ongoing challenges facing Canada's regulated cannabis market as illegal operators undercut licensed retailers.
FDA Drafts CBD Enforcement Rules, Ending Regulatory Gray Area
Federal regulators advance compliance framework to White House review after years of hands-off approach to cannabidiol market oversight.
Cannabis Media Coverage Drives Consumer Interest But Not Stock Returns
Hollywood's cannabis portrayals boost brand awareness without translating to measurable revenue growth for public operators, highlighting sector's marketing challenges.
Chile's Political Shift Creates Cannabis Investment Uncertainty
New conservative leadership in Chile threatens to derail cannabis reforms, creating headwinds for international operators eyeing Latin American expansion opportunities.
Newsom Leverages Trump Gaffe to Spotlight Federal Cannabis Reform
California governor uses presidential slip-up to highlight state-federal cannabis policy divide, underscoring ongoing regulatory uncertainty facing industry investors.
NJ Cannabis Retail Matures as Local Operators Mark First Year Milestones
New Jersey's adult-use market shows stability as independent dispensaries reach profitability benchmarks, signaling sector consolidation ahead.
Colorado Rejects Cannabis Tax Hike Ballot Measure
Legislative committee blocks proposal to raise marijuana and alcohol taxes for mental health funding, preserving current tax structure ahead of November elections.
Ohio Hemp-Infused Beverage Market Stalls as Legal Battle Escalates
Brewers challenge Governor DeWine's veto of hemp THC provisions, citing millions in stranded inventory as regulatory uncertainty threatens emerging market segment.
European Regulations Threaten Canada's Cannabis Export Dominance
Rising EU production capacity and stricter import rules challenge Canadian exporters' market share as European nations prioritize domestic cultivation over imports.
Congressional Report Signals Hemp THC Crackdown Ahead
New congressional analysis outlines federal enforcement priorities on hemp-derived THC products while detailing limited scope of pending marijuana rescheduling efforts.
Americans View Cannabis as More Moral Than Gambling in New Survey
Shifting public sentiment on cannabis morality could accelerate institutional investment and federal reform, creating new tailwinds for sector valuations.
Oklahoma House Blocks Employer Cannabis Firing Rights Expansion
Oklahoma legislators reject bill expanding employer authority to terminate medical cannabis patients, preserving current worker protections in key market.
Mass. Legal Cannabis Captures 73% Market Share, Squeezing Illicit Trade
Massachusetts Cannabis Control Commission data shows licensed dispensaries now serve nearly three-quarters of state consumers, marking a decisive shift from black market.
Colorado Lawmakers Block Cannabis Tax Hike for Mental Health Funding
Legislative committee unanimously rejects proposal that would have raised $44M annually through higher cannabis and alcohol excise taxes for Aurora hospital project.
Cannabis Genetics Drive $30B Market as Cultivators Race for Premium Strains
Proprietary genetics emerge as key differentiator in commoditizing cannabis market, with seed technology driving cultivation margins and brand premiums.
CoreWeave's AI Infrastructure Costs Signal Caution for Cannabis Tech
Despite explosive revenue growth, CoreWeave's massive capital requirements highlight risks facing cannabis companies investing in AI infrastructure and cloud computing solutions.
AI Chip Demand Surge Could Transform Cannabis Tech Infrastructure
Nvidia's latest developer conference signals accelerating AI adoption that may reshape cannabis cultivation, processing, and retail operations across the industry.
FDA Cannabis Enforcement Policy Heads to White House for Final Review
Federal regulators advance new CBD enforcement framework that could reshape multi-billion dollar hemp market and clarify compliance standards.
Federal Court Reverses Health Canada Cannabis Security Denial
Canadian court ruling challenges Health Canada's cannabis security clearance process, potentially streamlining licensing for operators and reducing regulatory bottlenecks.
PA Senate Targets Hemp THC Market as Federal Crackdown Looms
Pennsylvania lawmakers move to ban most hemp-derived THC products ahead of November federal restrictions, creating regulatory uncertainty for hemp companies.
Cannabis Breaks Into Oscar Swag Bags as Premium Market Expands
Academy Award nominees receive cannabis products in $350K gift packages, highlighting the industry's push into luxury consumer segments and mainstream acceptance.
Missouri Tightens Cannabis Licensing Rules After Ownership Fraud Probe
State lawmakers approve new regulations targeting fraudulent microbusiness licenses following investigation into illegal ownership structures.
Cannabis Pharma Trials Advance as Dosing Research Gains Industry Focus
University clinical research into THC therapeutic windows reflects growing pharmaceutical validation of cannabis compounds for medical applications.
Lab Equipment Consolidation Accelerates as Cannabis Testing Expands
Laboratory supply chains face pressure as cannabis testing requirements grow nationwide, creating opportunities for specialized equipment providers.
Cannabis Gains Social Acceptance, Outpacing Gambling in Moral Survey
New Pew Research data shows Americans view cannabis use as more morally acceptable than gambling or abortion, signaling continued mainstream adoption.
AI Integration Accelerates Across Cannabis Operations and Analytics
Artificial intelligence adoption in cannabis spans cultivation optimization, compliance tracking, and market analytics as operators seek efficiency gains amid margin pressure.
Canopy Growth Closes MTL Cannabis Buyout in Consolidation Play
CGC finalizes acquisition of Quebec-focused MTL Cannabis as industry consolidation accelerates amid margin pressures and market maturation.
Cannabis Data Centers Emerge as AI Infrastructure Play
Applied Digital's rapid data center expansion signals new revenue streams for cannabis companies exploring AI applications in cultivation and processing operations.
Rhode Island Cannabis License Lottery Stalls as Market Expansion Hangs
State regulators postpone decision on 20 new dispensary licenses, creating uncertainty for operators and potential market consolidation opportunities.
Virginia Clears Adult-Use Cannabis Sales, Opening New Market Corridor
Virginia legislature approves adult-use cannabis sales framework, creating potential $3B+ market and East Coast expansion opportunities for multi-state operators.
Missouri Tightens Cannabis Licensing Rules to Block Market Manipulation
State lawmakers advance reforms targeting abuse of lottery-based microbusiness permits as operators exploit regulatory gaps to consolidate market control.
Cannabis Legalization Cuts Crime Rates, Boosting Industry Investment Case
New research shows adult-use cannabis reduces violent crime while medical programs cut property crime, strengthening the economic argument for legalization.
Tilray's Multi-Sector Bet Tests Cannabis Investor Patience
TLRY's expansion beyond cannabis into alcohol and wellness creates revenue diversification but raises questions about capital allocation efficiency and core competency focus.
Tilray's Beverage Expansion Tests Cannabis Diversification Playbook
TLRY's alcohol portfolio now generates more revenue than cannabis operations, marking a strategic pivot that challenges traditional sector valuations.
New Mexico Allocates $800K for Psilocybin Therapy in Budget Win
State becomes latest to fund psychedelic research with taxpayer dollars, signaling mainstream acceptance that could accelerate sector investment flows.
South Africa's Cannabis Licensing Creates Two-Tier Market Structure
Traditional cultivators face enforcement while commercial exporters secure permits, highlighting regulatory disparities that could reshape global supply chains.
Federal Drug Testing Rules Stay Unchanged as Cannabis Rescheduling Stalls
HHS confirms no workplace policy updates planned while Trump's cannabis rescheduling order remains incomplete, maintaining regulatory uncertainty for industry.
Virginia Sets 2027 Launch Date for Adult-Use Cannabis Market
Virginia legislators finalize timeline for recreational cannabis sales, creating new East Coast market opportunity for operators and investors.
Virginia Advances Cannabis Sales Bill as East Coast Markets Expand
Virginia legislature passes retail cannabis legalization, adding momentum to East Coast expansion that could reshape regional market dynamics and MSO growth strategies.
Cannabis Retail Security Emerges as Key Investment Factor
Rising crime rates in key cannabis markets force operators to reassess security spending, impacting margins and location strategies across the industry.
Goldman Sachs Healthcare Picks Signal Pharma Interest in Cannabis
Major investment bank's healthcare recommendations may indicate growing institutional appetite for cannabis therapeutics as regulatory barriers soften.
Healthcare Fund's $24.5M Immunovant Bet Signals Biotech Shift
Major healthcare hedge fund deploys significant capital into autoimmune specialist, highlighting institutional appetite for specialized therapeutic plays outside traditional pharma.
Alabama Medical Cannabis Market Opens After Multi-Year Regulatory Delays
Alabama's medical marijuana program nears operational launch, creating new revenue opportunities for MSOs and potentially validating Southeast expansion strategies.
Alabama Medical Cannabis Market Opens, Adding $50M Revenue Potential
Alabama's medical marijuana program finally launches after regulatory delays, creating new market opportunities for MSOs and potentially $50M in annual sales.
Healthcare Tech Selloff Creates Opportunities for Cannabis Ancillary Plays
Payment processing and revenue cycle management solutions gain traction as cannabis operators seek healthcare-grade compliance infrastructure.
Cannabis Wholesale Crash Deepens: $213M January Sales Drop 29% YoY
January wholesale cannabis revenue plunged to $213.4M, marking a brutal 29% year-over-year decline while inventory levels hold steady despite oversupply concerns.
Texas Hemp Industry Faces Enforcement Chaos as New Rules Take Effect
Regulatory confusion threatens Texas hemp operators with increased raids and compliance costs, creating market uncertainty for industry players nationwide.
Texas Hemp Regulatory Confusion Threatens Industry Compliance Crackdown
Unclear state hemp regulations create enforcement risks for Texas cannabis businesses as regulatory gaps fuel compliance uncertainty across the sector.
NY Cannabis Data Contradicts Prohibitionist Claims About Market Failure
Smart Approaches to Marijuana overstates evidence against New York's legal cannabis program, while market fundamentals show steady progress despite implementation challenges.
New York Cannabis Data Contradicts Industry Critics' Failure Claims
Anti-legalization groups question NY's cannabis rollout, but market metrics tell different story for operators and investors tracking state progress.
Oklahoma Blocks Employer Cannabis Termination Bill in Victory for Workers
Oklahoma House defeats legislation expanding employer rights to terminate medical marijuana patients, protecting workforce access in key cannabis market.
Oklahoma House Blocks Employer Cannabis Termination Expansion Bill
Oklahoma legislators reject measure expanding employer rights to terminate medical cannabis patients, signaling continued workforce protection trend across legal states.
Georgia House Approves Medical Cannabis Program Overhaul
Bipartisan legislation modernizes state's restrictive medical marijuana framework, potentially opening new market opportunities for operators.
Virginia Clears Recreational Cannabis Sales Bill for Governor Approval
Virginia legislature advances recreational marijuana sales legislation to governor's desk, potentially opening new market opportunities for cannabis operators.
Mass Cannabis Market Captures Majority Share as Rollback Vote Looms
Massachusetts regulated cannabis market achieves majority consumer capture ahead of potential November rollback vote, validating legal framework's competitive strength.
SNDL Posts Record Cannabis Revenue on Edibles, International Push
SNDL Inc reports $103.7M Q4 cannabis revenue, hitting full-year records as edibles and international expansion offset domestic headwinds.
New Hampshire Cannabis Bills Fail as Northeast Legalization Stalls
NH House kills marijuana and psilocybin bills without votes, highlighting regulatory headwinds facing cannabis operators in Northeast markets.
Georgia House Advances Medical Cannabis Expansion in Key Vote
Georgia lawmakers approve broader patient access and vaping rights, signaling continued state-level momentum despite federal constraints on cannabis markets.
Tennessee Hemp Crackdown Exposes 650+ Unlicensed Retailers
State regulators discover widespread non-compliance as hemp market regulation tightens, signaling enforcement risks across multi-billion dollar industry.
Manitoba Cuts Cannabis Distributors to Three, Forcing Supply Chain Shakeup
MBLL's distributor reduction creates compliance challenges for suppliers and potential market access risks by April 2026.
Delaware Advances Hospital Cannabis Access for Terminal Patients
Delaware Senate unanimously passes legislation allowing terminally ill patients to use medical cannabis in hospitals, expanding healthcare access in regulated markets.
Raw Cannabis Compounds Drive Next Wave of Premium Product Development
Advanced extraction methods unlock acidic cannabinoids, creating new revenue streams for manufacturers targeting wellness consumers willing to pay premium prices.
Federal Cannabis Rescheduling Won't Fix Banking, Tax Barriers
UC researchers call rescheduling a transitional step requiring broader reforms to unlock industry's full potential
Cannabis Nostalgia Marketing Drives Premium Strain Revenue Growth
Legacy strain names from the 80s and 90s command premium pricing as cultivators capitalize on consumer nostalgia, boosting margins across the sector.
Fair Future Act Targets Cannabis Housing Bias, Boosting Market Access
Bipartisan housing discrimination bill could expand cannabis consumer base by removing decades-old barriers for Americans with prior marijuana convictions.
Village Farms Cannabis Revenue Jumps 18% in Q4 on Export Momentum
VFF's Canadian cannabis division posts $52.7M quarterly sales as international expansion drives growth beyond domestic market saturation.
Canada Seizes 1,066kg Cannabis Export Shipment in Regulatory Crackdown
Border officials intercept massive illegal cannabis export operation from Toronto area, highlighting ongoing regulatory enforcement challenges facing licensed operators.
Cannabis Telemedicine Models Eye US Market Entry Amid Regulatory Shifts
European telehealth platforms demonstrate scalable cannabis delivery models as US regulatory barriers create market entry opportunities worth billions in untapped revenue.
Hash-Focused Genetics Drive New Cannabis Cultivation Economics
Cultivators prioritize resin production over flower aesthetics as concentrate markets reshape breeding strategies and profit margins across the supply chain.
Hash-Focused Cannabis Genetics Drive New Revenue Streams for Growers
Cannabis cultivators pivot from flower-first breeding to resin-optimized strains as concentrate markets expand, fundamentally altering cultivation economics.
Caribbean Cannabis Reform Hits Colonial Roadblock in Bermuda
Regional legalization momentum faces UK interference as territories navigate sovereignty constraints while independent nations advance reform agendas.
Caribbean Cannabis Reforms Hit Colonial Roadblock in Bermuda
Grenada's legalization drives regional momentum while British oversight blocks Bermuda's cannabis progress, creating uneven market development across Caribbean territories.
CBD and CBG Target Fatty Liver Disease in New Medical Research
Research identifies cannabinoids as potential treatments for chronic liver disorder, opening new pharmaceutical pathways for cannabis companies developing medical applications.
Texas Hemp Crackdown Eliminates $200M Smokable Market by March 31
Texas health regulators ban smokable hemp products effective March 31, forcing retailers to clear inventory while imposing stricter testing and packaging rules on remaining edibles.
TD Garden Owner Targets Cannabis Retailer in Trademark Battle
Delaware North sues Massachusetts dispensary over Boston Garden name usage, highlighting IP risks facing cannabis operators as industry matures.
Minnesota Expands Tribal Cannabis Framework with Ninth Compact Agreement
Gov. Walz signs cannabis compact with Lower Sioux Indian Community, extending tribal business operations beyond reservation boundaries in growing state market.
Minor Cannabinoids Drive New Revenue Streams as Market Matures
Specialized cannabinoid companies capitalize on growing demand for compounds beyond THC and CBD, creating premium product categories worth billions.
Argentina Cannabis Merger Signals South American Market Consolidation
Flowers & Terps-Universal Growing partnership represents first major consolidation play in region's emerging cannabis sector, targeting export opportunities.
Argentina Cannabis Consolidation Signals Regional Market Maturation
Flowers & Terps-Universal Growing merger creates vertically integrated operator as South American cannabis markets evolve beyond fragmented startup phase.
AI Reshapes Cannabis Medicine as Precision Treatment Era Begins
Artificial intelligence technologies drive cannabis medicine toward data-driven dosing and personalized therapies, creating new market opportunities.
Aurora Cannabis Challenges Veterans Affairs Medical Cannabis Cuts
ACB disputes government's $4.4B savings claim as Veterans Affairs moves to slash medical cannabis benefits, setting up regulatory battle that could impact sector demand.
South Carolina Moves to License THC Beverages Under Alcohol Framework
Senate bill would create retail distribution system for low-dose hemp drinks, opening new revenue channels for cannabis beverage companies in the Southeast.
Florida Cannabis Legalization Push Faces 2026 Setback After Court Ruling
Smart & Safe Florida loses 70,000 signatures as Supreme Court upholds stricter ballot rules, complicating cannabis reform timeline in nation's third-largest state.
Ontario Bans 'Dispensary' Term, Driving Cannabis Sales Underground
Provincial regulators force retailers to abandon popular search term, potentially costing legal market millions in lost consumer traffic to illicit competitors.
Colombia's Petro Challenges Drug War, Signals Cannabis Policy Shift
President's UN speech attacking prohibition could accelerate Latin American cannabis reforms, creating new market opportunities for investors tracking regional expansion.
Colombia's Petro Calls Cannabis Prohibition Outdated at UN Assembly
Colombian President challenges global drug war policies, distinguishing cannabis from harder drugs in speech that could accelerate regional legalization trends.
Cannabis Culture Shift: Female Leadership Drives Market Evolution
Portland's cannabis scene exemplifies broader industry transformation as female entrepreneurs reshape market dynamics and consumer engagement strategies.
Premium Cannabis Brands Drive Market Evolution Through Product Innovation
Craft cannabis companies reshape consumer preferences with sophisticated product design, signaling broader industry maturation beyond commodity flower sales.
ECS Research Drives Cannabis Medical Market to $8.9B by 2028
New endocannabinoid system research validates therapeutic applications, accelerating medical cannabis adoption and pharmaceutical investment across major markets.
UK Medical Cannabis Patients Launch Anti-Discrimination Support Network
New patient advocacy service addresses workplace and social barriers facing UK medical cannabis users, potentially expanding market access for licensed operators.
Tennessee Lawmakers Link Cannabis Revenue to Infrastructure Funding
Democratic legislators propose adult-use cannabis bill directing tax revenue toward road repairs, joining growing trend of states using marijuana taxes for infrastructure projects.
Poland's Cannabis Telemedicine Crash Exposes Critical Regulatory Risk
Poland's medical cannabis dispensing volumes plummeted 50% after regulatory intervention, highlighting the vulnerability of telemedicine-dependent markets worldwide.
Florida's Medical Cannabis Market Shows Troubling Signs for Investors
Florida's medical marijuana sector faces mounting challenges that could signal broader industry headwinds for public cannabis companies nationwide.
Florida Cannabis Market Faces Operational Headwinds Amid Regulatory Flux
Florida's medical cannabis sector confronts mounting challenges as operators navigate pricing pressures and regulatory uncertainty ahead of potential recreational legalization.
Cresco Labs Revenue Falls to $162M Despite Margin Recovery in Q4
Cannabis operator reports sequential margin improvement but continues facing top-line headwinds as industry consolidation pressures persist.
UK Medical Cannabis Access Crisis Threatens Market Growth Potential
New advocacy push highlights NHS prescription barriers that limit patient access, constraining the UK's medical cannabis market development and commercial opportunities.
Cannabis Brands Eye Luxury Perfume Playbook for Premium Positioning
Industry leaders study fragrance sector's approach to sensory branding, quality control, and cultural narratives as cannabis matures beyond commodity pricing.
Cannabis Data Deluge Creates Analysis Paralysis for Investors
Overwhelming volume of cannabis market research creates challenges for investors seeking reliable data to guide investment decisions in volatile sector.
UK Clears CBD Endometriosis Trial as Medical Cannabis Market Expands
Ananda Pharma launches NHS-supported Phase 2 study targeting endometriosis pain, marking regulatory progress for medical cannabis applications in women's health.
Hash Burger Strain Recognition Signals Premium Cannabis Market Evolution
Leafly's 2025 Strain of the Year selection highlights growing consumer sophistication and premium product demand driving dispensary differentiation strategies.
Hash Burger Named 2025 Strain of the Year as Premium Cannabis Demand Surges
Leafly's annual strain recognition highlights evolving consumer preferences driving dispensary sales and cultivator revenue growth across regulated markets.
Hash Burger Named 2025 Strain of the Year Drives Retail Competition
Leafly's annual strain designation creates marketing opportunities for dispensaries as retailers leverage award recognition to differentiate product offerings and capture market share.
Hash Burger Named 2025 Strain of Year Signals Premium Cannabis Shift
Leafly's strain selection highlights consumer demand for craft genetics as dispensaries pivot toward higher-margin premium products amid pricing pressure.
February Cannabis Sales Drop 3.6% as Industry Faces Demand Headwinds
Multi-state cannabis sales fell 3.6% month-over-month in February, though daily averages improved 6.7% when adjusted for calendar differences across 15 tracked markets.
Blunt Market Share Drives Cannabis Brand Differentiation Strategy
One-third of cannabis consumers prefer blunts over joints, creating untapped revenue streams for brands targeting this premium consumption segment.
Cannabis Stocks Drop 10.6% in January After December Rally Fades
Global Cannabis Stock Index falls to 5.89 as sector volatility continues into 2025 following mixed 2024 performance.
Cannabis Stocks Tumble 10.6% in January After December Rally Fades
Global Cannabis Stock Index drops to 5.89 as sector volatility continues into 2025, erasing December gains and extending annual decline trends.
Cannabis Astrology Marketing Drives Consumer Engagement in 2026
Cannabis brands increasingly leverage astrological themes to differentiate products and capture consumer attention in oversaturated markets.
Cannabis Wellness Trends Drive Q1 2026 Consumer Personalization Push
Astrological cannabis matching emerges as latest personalization trend, signaling broader shift toward premium wellness products in mature markets.
Maryland Cannabis Market Tests Limited License Model Amid Expansion
Maryland's restricted licensing approach creates unique competitive dynamics as operators navigate scaling challenges in the state's evolving adult-use framework.
CBG Market Heats Up as Research Validates Health Applications
Emerging cardiovascular and antioxidant research drives commercial interest in cannabigerol, creating new revenue streams for cannabis operators.
Curaleaf Posts Modest Q4 Growth Amid Cannabis Market Headwinds
Multi-state operator delivers $333M quarterly revenue with 49% margins, generating $152M operating cash flow as international expansion accelerates.
Curaleaf Posts $333M Q4 Revenue as International Gains Offset US Headwinds
Cannabis operator delivers 2% quarterly growth with $51M international revenue, while maintaining 49% gross margins and generating $152M annual operating cash flow.
Cannabis Buybacks: When Share Repurchases Destroy Shareholder Value
Cannabis companies increasingly turn to share buybacks, but these programs often signal poor capital allocation rather than confidence in growth prospects.
Cannabis Stock Buybacks: When Capital Returns Backfire
Share repurchase programs can destroy value for cannabis investors when companies lack sustainable cash flows and growth capital discipline.
Medical Cannabis Oversight Gap Creates Investment Risk for Operators
Clinical accountability standards lag behind market expansion, creating regulatory uncertainty that threatens valuations across medical cannabis sector.
Green Thumb Industries Posts Strong Q4 Gains, Margin Expansion Continues
GTBIF delivers robust fourth quarter performance with improved profitability metrics, reinforcing its position as a top-tier cannabis operator in competitive markets.
Green Thumb Revenue Surge Drives Profitability Gains in Q4 2025
GTBIF delivers strong Q4 results with revenue growth and improved margins as multi-state operator capitalizes on expanding legal markets and operational efficiency gains.
Poland Medical Cannabis Volumes Surge 12% as Market Exits Regulatory Chaos
Polish pharmacies dispensed 5,450kg of dried cannabis in 2025, marking full recovery from previous regulatory disruptions and signaling European expansion opportunities.
Cannabis Retail Faces Extended Downturn Through 2026
Industry consolidation accelerates as oversupply and margin compression force retailers into survival mode for next two years.
European Cannabis Operator Scales to 18 Countries Amid Market Turmoil
Somai Pharmaceuticals expands global footprint while US MSOs face consolidation pressures and European markets open new revenue channels.
NIH Study Validates Acidic Cannabinoids as Next Investment Frontier
Federal research confirms therapeutic potential of raw cannabis compounds, opening new product categories and IP opportunities for cannabis companies.
UK Court Overturns Medical Cannabis DUI Case in Landmark Ruling
British appeals court reverses wrongful conviction, exposing flawed drug testing protocols that threaten medical cannabis adoption and industry growth prospects.
UK Medical Schools Enter Cannabis Training as Market Demand Surges
Bristol Medical School launches pioneering cannabis medicine curriculum as UK's £1.2B medical cannabis market drives physician education demand.
States Scramble as Federal Hemp Crackdown Looms
Congressional moves to ban intoxicating hemp products trigger state-level regulatory responses, creating uncertainty for operators like Hemp Inc and the broader sector.
NY Governor Eyes Cannabis Budget Reforms Amid Market Struggles
Hochul prepares regulatory changes as Empire State operators face mounting financial pressure from oversupply and pricing collapse.
California Cannabis Chief Exit Signals Regulatory Reset for $6B Market
Leadership transition at California's cannabis authority creates uncertainty for operators as the state grapples with illicit competition and tax reform pressures.
Trump Cannabis Order Triggers Industry Rally Across MSO Stocks
Executive action on federal rescheduling sends multi-state operators surging as investors price in regulatory shift potential
California Cannabis Tax Cuts, Hemp Restrictions Clear Legislature
New legislation reduces cannabis tax burden while tightening hemp regulations, creating mixed market signals for operators in the nation's largest cannabis market.
NY Cannabis Operators Challenge Municipal Bans in Court Showdown
Legal battles brewing as cannabis companies fight local zoning restrictions that threaten market rollout and operator revenues across New York state.
NIDA Ends Ole Miss Cannabis Monopoly After 50-Year Research Deal
Federal research agency terminates exclusive supply contract, opening door for competitive sourcing that could reshape cannabis science funding and market access.
NY Cannabis Control Board Installs New Leadership Amid Market Turmoil
New York's struggling cannabis market gets fresh regulatory leadership as the state grapples with illegal competition and operator financial distress.
California Eyes Cannabis Tax Cuts as Hemp Regulation Tightens
State lawmakers advance dual cannabis agenda targeting tax relief for struggling operators while cracking down on intoxicating hemp products flooding retail markets.
NY Cannabis Licensing Bottleneck Sparks Investor Concerns
Frustrated applicants disrupt regulatory meeting as New York's licensing delays threaten market expansion and multi-state operator growth strategies.
GOP Lawmakers Target Intoxicating Hemp in FDA Oversight Hearing
Republican Congress members intensify scrutiny of psychoactive hemp products during FDA hearing, signaling potential regulatory crackdown that could reshape the $28 billion hemp market.